Company Yunkang Group Limited

Equities

2325

KYG9889T1067

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for Yunkang Group Limited

EPS Revisions

Annual profits - Rate of surprise

Sector Medical & Diagnostic Laboratories

Market Closed - Hong Kong S.E. Other stock markets 04:08:09 2024-05-16 am EDT			5-day change	1st Jan Change
10.66 ^HKD	-2.02%		-3.09%	-13.33%

May. 13	Yunkang Group Sees Potential in Outsourcing Lab Testing Services for China's Public Hospitals	MT
Apr. 05	Everbest Machinery Industry to Set Up 30 Million Yuan Joint Venture	MT

Yunkang Group Ltd is a China-based Company mainly engaged in the provision of diagnosis testing services. The Company operates three segments. Diagnosis Testing segment provides diagnosis testing to hospital and non-medical clients, mainly including routine diagnostic testing, routine pathological examination, infectious disease diagnostic testing, genetic disease diagnostic testing and early cancer detection. Hospital Management Business segment provides management services for the community clinics. Research & Development Institution segment is engaged in the research and development of testing kits. The Company primarily provides services for hospitals and other medical institutions, and commercial entities such as financial institutions and insurance companies.

Number of employees: 1,510

HKD in Million	2022	Weight	2023	Weight	Delta
Diagnostic Testing Services for Medical Institution Alliances 48.3 %	1,954	44.7 %	476	48.3 %	-75.64%
Diagnostic Outsourcing Service 46.4 %	2,261	51.8 %	457	46.4 %	-79.78%
Diagnostic Testing Services for Non-medical Institutions 5.3 %	153	3.5 %	52	5.3 %	-66.02%

HKD in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	4,368	100.0 %	985	100.0 %	-77.45%

Managers	Title	Age	Since
Yong Zhang CEO	Chief Executive Officer	52	18-07-19
Ying Jia Lin DFI	Director of Finance/CFO	45	21-02-06
Tie Ding Wang PRN	Corporate Officer/Principal	58	-
Shang Hua Hu PRN	Corporate Officer/Principal	55	-
Xu Bo Wang PRN	Corporate Officer/Principal	49	-
Lok Yee Chan SEC	Corporate Secretary	35	21-01-10

Members of the board	Title	Age	Since
Shi You Yu BRD	Director/Board Member	67	-
Shao Hua Xie BRD	Director/Board Member	52	-
Ping Hui Wang BRD	Director/Board Member	64	23-08-29
Rui Hua Wang BRD	Director/Board Member	62	22-07-10
Yong Zhang CEO	Chief Executive Officer	52	18-07-19
Luo Huang BRD	Director/Board Member	44	22-08-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	621,250,500	161,359,500 ( 25.97 %)	0	25.97 %

Name	Equities	%	Valuation
Yong Zhang 40.26 %	250,108,000	40.26 %	355 M $
Daan Gene Technology Co. Ltd. 33.77 %	209,783,000	33.77 %	298 M $

Yunkang Group Ltd.

No. 6 Lizhishan Road Science City

, Guangzhou

http://www.yunkanghealth.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.856 CNY

Average target price

12.93 CNY

Spread / Average Target

+31.17%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
YUNKANG GROUP LIMITED	-13.33%	837M
SONIC HEALTHCARE LIMITED	-15.71%	8.57B
RADNET, INC.	+65.86%	4.3B
SYNLAB AG	-9.46%	2.47B
DR. LAL PATHLABS LIMITED	-2.16%	2.46B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44.11%	2.31B
NEOGENOMICS, INC.	-7.48%	1.93B
FLEURY S.A.	-18.51%	1.53B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-41.75%	1.2B
METROPOLIS HEALTHCARE LIMITED	+11.31%	1.14B

Medical & Diagnostic Laboratories